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CILIARY neurotrophic factor (CNTF) supports the survival of 
embryonic motor neurons in vitrol,2 and in vivo3 and prevents 
lesion-mediated degeneration of rat motor neuron~ during early 
post-natal stages4 • Here we report that CNTF greatly reduces all 
the functional and morphological changes in pmnlpmn mice5, an 
autosomal recessive mutant leading to progressive caudo-cranial 
motor neuron degeneration. The first manifestations of progressive 
motor neuronopathy in homozygous pmnl pmn mice become 
apparent in the hind limbs at the end of the third post-natal week 
and all the mice die up to 6 or 7 weeks after birth from respirato~ 
~aralysis. Treatment .with CNTF p-rolongs- survival- and greatly 
Imp~oves ~otor functIon of these mice. Moreover, morphological 
mamfestatJons, such as loss of motor axons in the phrenic nerve 
and degeneration of facial motor neurons, were greatly reduced 
by CNTF, although the treatment did not start until the first 
symptoms of the disease had already become apparent and substan-' 
tial degenerative changes were already present. The protective and 
r~storative effects of CNTF in this mouse mutant give new perspec-
tIves for the treatment of human degenerative motor neuron dis-
eases with CNTF. 
We hav~ e~aluate~ the effects of CNTF in the pmn/ pmn 
mouse, whIch IS an ammal model for human spinal motor neuron 
disease5 . In contrast to two other mouse mutants wobbler6- 8 
and mnd 9,1O, the manifestations of motor neuron d~generation 
in pmn/ pmn mice appear earlier and progress more rapidly. In 
4-wee~-0Id pmn/ pmn mice, the number ofaxons of the phrenic 
nerve IS already highly reduced, indicating that at this time the 
TABLE 1 Effect of CNTF treatment on the number of facial motor neurons 
and phrenic nerve axons in pmnl pmn mice 
pmn mice 
(40-50 days old) 
CNTF-treated pmn mice 
(40-48 days old) 
Healthy control mice 
(littermates) 
Number of 
facial 
motor neurons 
1,881±199* 
(n=6) 
2,679±108* 
(n=7) 
3,108±153 
(n=5) 
Number of 
phrenic 
nerve axons 
87±4* 
(n=7) 
144±22* 
(n=7) 
ND 
The brain stem of mice perfused with 4% formaldehyde was embedded 
in paraffin, serial sections 7 -fLm thick were stained with cresyl violet, and 
the nucleoli of facial motor neurons were counted in every fifth section on 
both sides as previously described" Counts were not corrected for spl it 
nucleoli4 ,15, The mean of the counts on both sides was used for each animal. 
Phrenic nerves were prepared after perfusion of the animals with 4% 
formalin, Nerves were postfixed in 4% formalin, dehydrated, then 5-fLm 
transverse sections made and stained according to ref, 16, Myelinated 
axons were counted from photographs taken from nerve sections under the 
light microscope, Data shown are means ± s,e.m, for each group, ND, not 
determined, 
* Statistical significance was tested by Student's t-test, P< 0,0005, 
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disease has already reached an advanced stage. The motor 
neurons of pmn/ pmn mice first undergo a reduction in cell size, 
then chromatolysis and finally cell death, similar to the patho-
logical changes seen in many cases of human motor neuron 
diseases ll. The gene defect responsible for the motor neu'ron 
changes in pmn/ pmn mice is still unknown. But an insufficient 
or defective expression of CNTF does not seem to be responsible 
for the degenerative changes. Northern blots of sciatic nerve 
reveal CNTF transcripts with similar size and intensity to those 
of the healthy controls. Western blots from sciatic and facial 
nerve extract are indistinguishable from those of controls and 
the same extracts contain comparable CNTF biological activity, 
as determined in the embryonic chick ciliary neuron survival 
assay (data not shown). 
Because intravenously injected CNTF has a half-life of only 
a few minutes (F. Dittrich and M.S., unpublished results) and 
pmn/ pmn mice do not tolerate repetitive daily injections of 
CNTF, and because the available implantable infusion pumps 
are too large for 3-4 week-old mice, we established a stable cell 
line by transfection of mouse D3 cells l2 with a leader 
sequence/CNTF genomic DNA construct (Fig. 2a). CNTF is 
synthesized and released by these cells in high quantities. The 
effect of intraperitoneal injection of 5 x 107 CNTF-secreting D3 
cells was compared with untreated controls from the same litters 
and with animals injected with untransfected D3 stem cells 
between post-natal day 20 and 21 (Fig. 1). Because homozygous 
pmn/ pmn mice cannot be recognized before the onset of first 
paralytic symptoms, an earlier start of the treatment was pre-
cluded. Of four mice injected with untransfected D3 cells, three 
mice died between postnatal day 34 and 36. In comparison, five 
out of eight untreated pmn/ pmn mice and seven out of eight 
FIG, 1 A. Effect of CNTF on the survival of pmnl pmn mice, Survival of eight 
untreated pmnlpmn mice (dashed-line); eight pmnlpmn mice injected at 
post-natal day 20 or 21 with 5 x 107 CNTF-secreting D3 cells (solid line); 
and four pmnl pmn mice injected with 5 x 107 untransfected D3 cells (dotted 
line) are shown, Triangles, time of cell injection; squares, time of death, B, 
Pmnl pmn mice of two independent experiments at 35 ,(1 and 2) and 40 (3 
and 4) days old, a, C, CNTF-treated pmnlpmn mice; b, d, untreated pmnlpmn 
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FIG. 2 a, Map of the construct used for stable transfection of mouse D3 
stem cells: a fragment containing mouse CNTF genomic DNA, which includes 
the whole coding regions of exon I and 11 and a roughly 1,000-base pair (bp) 
intron, was cloned 3' of a complementary DNA fragment coding for the first 
20 amino acids of mouse prepro-nerve growth factor (starting from methion-
ine -121, which has been suggested as the translation initiation site for 
human and mouse NGF17), which includes the entire signal peptide 
sequence1 8 This construct was cloned into the pRc/CMV expression vector 
(In VitroGen). After linearization with Pvul, 25 fLg plasmid DNA were used 
for transfection of 5 x 106 mouse D3 embryonic stem cells by electropor-
ation. Clones were selected by G 418 treatment1 2 for neomycin resistance 
and analysed for CNTF expression. In contrast to cells transfected with 
native CNTF, which do not release CNTF19.20, more than 70% of the total 
cil iary neuronal survival activity was released from these cells into the 
culture medium after 40 h in culture. b, Morphology of the intraperitoneal 
tumours that had formed 3 weeks after intraperitoneal injection of 5 x 107 
D3 cells in a pmnl pmn mouse at postnatal day 21. Paraffin sections were 
prepared and stained with haematoxyl in- eosin. Scale bar, 100 fLm . c, CNTF 
biological activity in: I, Sera from pmn/ pmn mice after intraperitoneal injec-
tion of transfected CNTF-secreting D3 cells. The survival of isolated chick 
embryonic day-8 ciliary neurons was determined13 after addition of sera 
from pmnl pmn mice at dilutions from 1:1,000 to 1:100. One trophic unit 
is defined here as the volume of serum per ml of medium that supports 
half-maximal survival of the cultured neurons. 11 , A neutralizing antiserum 
against rat CNTF2 1 (prepared by repeated immunization of a rabbit with rat 
CNTF) was used as a control for the specificity of the bioassay for CNTF. 
This antiserum (5 fLl ml - 1 medium), which completely abolished the survival 
effect of 1 ng CNTF in cultures of ciliary neurons, inhibited the survival 
activity observed with the sera shown in I. Ill , Sera from four untreated 
pmnl pmn mice and from one pmnl pmn mouse treated with untransfected 
D3 cells were also tested and were inactive at the same concentrations 
(dilution 1:1,000 to 1 :100 in the culture medium). 
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FIG. 3 Morphology of the facial nucleus (a, b) and 
phrenic nerve (c, d) of untreated pmnl pmn mice 
(a, c) and pmnl pmn mice injected with CNTF-
secreting D3 cells (b, d) . a, b, The motor neurons 
are more numerous, larger and vary less in dia-
meter in the CNTF-treated mouse (b) than in the 
untreated mouse (a). Chromatolysis tends to be 
less pronounced after CNTF-treatment. c, d, Distal 
phrenic nerves of an untreated pmnl pmn mouse 
at day 43 and of a CNTF-treated pmn/ pmn mouse 
at day 48. The nerve of the CNTF-treated animal 
(d) appears to be much better preserved and 
contains more myelinated axons than that of the 
untreated animal (c). Scale bars, 100 fLm (a, b), or 
50 fLm (c, d) . 
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CNTF-treated pmn/ pmn mice were still alive at postnatal day 
36. The fact that the intraperitoneal injection of untransfected 
D3 stem cells and the intraperitoneal growth of teratoma-like 
tissue (Fig. 2b) even increased the death rate in pmn/ pmn mice 
is a further demonstration that these animals are very sensitive 
to any kind of surgical intervention. 
Of eight CNTF-treated mice analysed, seven were still alive 
at postnatal day 40 when 50% of untreated pmn/ pmn mice had 
already died (Fig. lA). Moreover, these mice were capable of 
a better motor performance than the untreated pmn/ pmn mice. 
In contrast to the latter, they could still climb onto a ruler when 
allowed to grip it with their forepaws (Fig. lE). 
CNTF-treated and non-treated mice were killed between post-
natal day 40 and 48. After establishing deep ether anaesthesia, 
blood was taken by cardial puncture and the mice were perfused 
with 4% formaldehyde. Brain stem, phrenic nerve and tumour 
tissue formed in the peritoneal cavity of D3 cell-treated animals 
were prepared for morphological analysis. Sera were tested for 
CNTF activity (Fig. 2C)13.14 and significant levels of ciliary 
neuronal survival activity (492±282 trophic units ml-1 serum) 
were detected in the treated animals. Sera from untreated 
pmn/ pmn mice did not show noticeable survival activity. 
To determine motor neuron cell numbers we chose the facial 
nucleus because of the absence of interneurons in this well 
delineated structure. Interneurons present in the ventral horn 
of the spinal cord could erroneously be counted as atrophic 
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motor neurons. In comparison to untreated controls, the number 
of motor neurons in the facial nucleus was greatly decreased in 
pmn/ pmn mice and the treatment with CNTF exhibited a large 
protective effect (Table 1; and Fig. 3a, b) . CNTF supports the 
survival of single motor neurons in cell culturel4, suggesting 
that the protective and restorative effects of CNTF in pmn/ pmn 
mice are mediated directly on motor neurons rather than by 
skeletal muscle. Moreover, the number ofaxons in the phrenrc 
nerve was significantly increased by CNTF treatment, that is 
87±4 axons in untreated and l44±22 in CNTF-treated 
pmn/pmn mice (Table 1; and Fig. 3c, d). 
The data presented indicate that CNTF efficiently rescues 
motor neurons from degeneration in pmn/ pmn mice. Moreover, 
the large loss ofaxons in the phrenic nerve, presumably rep-
resenting the cause of death in pmn / pmn mice, can be sig-
nificantly reduced by CNTF treatment. Because initial symptoms 
cannot be recognized in pmn/ pmn mice before the third post-
natal week, it is to be expected that at this time the disease 
has already reached a relatively advanced stage, so that treat-
ment can only begin when the degeneration of motor neurons 
has already started. The number of phrenic nerve fibres is al-
ready reduced to 30% in 28-day-old pmn/ pmn mice5 . The ben-
eficial effects of CNTF in advanced stages of motor neuron de-
generation in pmnjymn mice indicates that treatment of 
human degenerative motor neuron diseases may eventually be 
possible. 0 
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